| Literature DB >> 27703431 |
Caimei Gu1, Xianying Yang1, Linfang Huang1.
Abstract
Cistanches Herba (family Orobanchaceae), commonly known as "desert ginseng" or Rou Cong Rong, is a global genus and commonly used for its neuroprotective, immunomodulatory, anti-oxidative, kidney impotence, laxative, anti-inflammatory, hepatoprotective, anti-bacterial, anti-viral, and anti-tumor effects in traditional herbal formulations in North Africa, Arabic, and Asian countries. The major bioactive compound present in this plant is phenylethanoid glycosides. In recent years, there has been great important in scientific investigation of the neuropharmacological effects of the bioactive compounds. The in vitro and in vivo studies suggests these compounds demonstrate neuropharmacological activities against a wide range of complex nervous system diseases which occurs through different mechanisms include improving immunity function and kidney aging, anti-lipid peroxidation, scavenging free radical, inducing the activation of caspase-3 and caspase-8. This review aims to summaries the various neuropharmacological effects and mechanisms of Cistanches Herba extracts and related compounds, including its efficacy as a cure for Alzheimer's disease and Parkinson's disease with reference to the published literature. Which provides guidance for further research on the clinical application of Cistanches Herba.Entities:
Keywords: Alzheimer’s disease; Cistanches Herba; Parkinson’s disease; neuropharmacological effect; review
Year: 2016 PMID: 27703431 PMCID: PMC5028387 DOI: 10.3389/fphar.2016.00289
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
The neuropharmacological effects of Cistanches Herba.
| Pharmacological effects | Traditional and clinical uses | Extracts/ Compounds | Minimal active concentration/ Dose | Animal/ Cell line | Duration | Control | References | |
|---|---|---|---|---|---|---|---|---|
| Anti-Alzheimer’s disease | In Alzheimer’s disease–like mice model caused by reducing quinolinic acid: enhance learning and memory, protect the brain damage | Glycosides | 62.5 mg/kg | Kunming mice | 17 days | Positive control: Duxil (8 mg/kg) | ||
| In Alzheimer’s disease–like mice model caused by amyloid β-protein: enhance learning and memory | Glycosides | 62.5 mg/kg | NIH mice | 17 days | Positive control: vitamin E (50 mg/kg) | |||
| In Alzheimer’s disease–like mice model caused by AlCl3: improve learning and memory problems | Glycosides | 62.5 mg/kg | Kunming mice | 20 days | Positive control: vitamin E (50 mg/kg) | |||
| In Alzheimer’s disease–like mice model caused by amyloid β-protein: enhance learning and memory | Glycosides | 25 mg/L | PC12 cell | 120 h | Positive control: Ginkgo laminae (40 mg/L) | |||
| In Alzheimer’s disease–like rat model caused by amyloid β-protein: improve learning and memory | Glycosides | 40 mg/kg | SD rats | 14 days | Positive control: vitamin E (50 mg/kg) | |||
| In aging rat model caused by | Alcohol extract | 2 g/kg/d | Wistar rat | 6 weeks | Not mentioned | |||
| In aging model caused by | Polysaccharide | 50 mg/kg | ICR mice | 4 weeks | Positive control: vitamin E (100 mg/mL) | |||
| Protective effect of | Polysaccharide | 2 g/kg/d | Wistar rat | 6 weeks | Not mentioned | |||
| Antagonize free radical damage, enhance heart and brain telomerase activity and immune function in aging mice | Polysaccharide | 25 mg/kg | ICR mice | 6 weeks | Normal control: normal saline | |||
| Protect cells from DNA damage, partly elucidating the mechanism of its effects and has potential anti-senescence activity | Acteoside and echinacoside | 100 mg/kg | SAM-P8 mice and control SAM-R1 mice | 4weeks | Not mentioned | |||
| In aging rat model caused by | Water extract | 40 mg/kg | ICR mice | 2 weeks | Normal control: normal saline | |||
| In aging rat model caused by | Echinacoside | 1 μM | Cell line MRC-5 | 48 h | Normal control: 250 μM H2O2 | |||
| Scavenge free radicals effectively and has protection against OH∙-induced DNA damage | Glycosides | 50 μL | Not mentioned | Not mentioned | Not mentioned | |||
| Anti-oxidative and Anti-apoptotic | Effect of Polysacchrides of | Polysacchrides | 50 mg/kg | NIH mice | 7 weeks | Positive control: vitamin E (35 mg/kg) | ||
| Protective effect of | Alcohol extract | 1 mg/g | SD rats | 4 weeks | Positive control: Oral Liquid of Rhodiola (0.5 Ml/100g) | |||
| Rescues the SHSY5Y neuronal cells from TNFα-induced apoptosis | Echinacoside | 1 mg/L | SH-SY5Y cell | 2 h | Not mentioned | |||
| Improve learning and memory | Effects of Cistanchis glycosides on the Learning and Memory of Kidney Yang Deficiency Mice | Glycosides | 100 mg/kg | Kunming mice | 30 days | Positive control: Jing guishen qi pill (1.5 g/kg) | ||
| The effect of phenylethanoid glycosides of the | Phenylethanoid glycosides | 10 mg/kg | Kunming mice | Not mentioned | Normal control: normal saline | |||
| Enhance the ability of learning and memorizing | Phenylethanoid glycosides | 50 mg/kg | Kunming mice | 30 days | Normal control: normal saline | |||
| Enhances learning and memory by inducing nerve growth factor | Glycosides | 10 μg/mL, 10 μL | PC12 cell line | 48 h | Positive control: nerve growth factor (50 μg/mL) | |||
| Improve the learning and memory ability | Glycosides | 2.5 mg/kg/d | Wistar rat | 14 days | Positive control: Oxiracetam (450 mg/kg/d) | |||
| Anti-Parkinson’s disease | Improves the behavioral and neurochemical outcomes in MPTP mice model of Parkinson’s disease and inhibits caspase-3 and caspase-8 activation in cerebellar granule neurons | Echinacoside | 5 mg/kg | C57BL/6 mice | 15 days | Positive control: amantadine (40 mg/kg) | ||
| Protect neurons | Acteoside | 25 mg/L | Wistar rat | 12 h | Not mentioned | |||
| Protecting effect of | Extract | 2 μg | SH-SY5Y cell | 48 h | Not mentioned | |||
| Reduce 6-OHDA-induced ROS production in PC12 cells | Echinacoside | 0.1 μM | PC12 cells | 24 h | Not mentioned |